The up‐regulation of IL‐4, IL‐5 and IL‐10 as seen in our MRMT‐1/Luc2‐bearing animals is in agreement with previous data and is indicative for cancer physiology modulation (Goldstein et al., 2011; Rosen et al., 1998). The gene discussed is IL5; the disease is cancer.